Cargando…
S-nitrosation impairs KLF4 activity and instigates endothelial dysfunction in pulmonary arterial hypertension
Krüppel-like factor 4 (KLF4) is a transcription factor with conserved zinc finger domains. As an essential regulator of vascular homeostasis, KLF4 exerts a protective effect in endothelial cells (ECs), including regulating vasodilation, inflammation, coagulation and oxidative stress. However, the un...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348764/ https://www.ncbi.nlm.nih.gov/pubmed/30660098 http://dx.doi.org/10.1016/j.redox.2019.101099 |
_version_ | 1783390161032183808 |
---|---|
author | Ban, Yiqian Liu, Yahan Li, Yazi Zhang, Yuying Xiao, Lei Gu, Yue Chen, Shaoliang Zhao, Beilei Chen, Chang Wang, Nanping |
author_facet | Ban, Yiqian Liu, Yahan Li, Yazi Zhang, Yuying Xiao, Lei Gu, Yue Chen, Shaoliang Zhao, Beilei Chen, Chang Wang, Nanping |
author_sort | Ban, Yiqian |
collection | PubMed |
description | Krüppel-like factor 4 (KLF4) is a transcription factor with conserved zinc finger domains. As an essential regulator of vascular homeostasis, KLF4 exerts a protective effect in endothelial cells (ECs), including regulating vasodilation, inflammation, coagulation and oxidative stress. However, the underlying mechanisms modifying KLF4 activity in mediating vascular function remain poorly understood. Recently, essential roles for S-nitrosation have been implicated in many pathophysiologic processes of cardiovascular disease. Here, we demonstrated that KLF4 could undergo S-nitrosation in response to nitrosative stress in ECs, leading to the decreased nuclear localization with compromised transactivity. Mass-spectrometry and site-directed mutagenesis revealed that S-nitrosation modified KLF4 predominantly at Cys437. Functionally, KLF4 dependent vasodilatory response was impaired after S-nitrosoglutathione (GSNO) treatment. In ECs, endothelin-1 (ET-1) induced KLF4 S-nitrosation, which was inhibited by an endothelin receptor antagonist Bosentan. In hypoxia-induced rat model of pulmonary arterial hypertension (PAH), S-nitrosated KLF4 (SNO-KLF4) was significantly increased in lung tissues, along with decreased nuclear localization of KLF4. In summary, we demonstrated that S-nitrosation is a novel mechanism for the post-translational modification of KLF4 in ECs. Moreover, these findings suggested that KLF4 S-nitrosation may be implicated in the pathogenesis of vascular dysfunction and diseases such as PAH. |
format | Online Article Text |
id | pubmed-6348764 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-63487642019-01-31 S-nitrosation impairs KLF4 activity and instigates endothelial dysfunction in pulmonary arterial hypertension Ban, Yiqian Liu, Yahan Li, Yazi Zhang, Yuying Xiao, Lei Gu, Yue Chen, Shaoliang Zhao, Beilei Chen, Chang Wang, Nanping Redox Biol Research Paper Krüppel-like factor 4 (KLF4) is a transcription factor with conserved zinc finger domains. As an essential regulator of vascular homeostasis, KLF4 exerts a protective effect in endothelial cells (ECs), including regulating vasodilation, inflammation, coagulation and oxidative stress. However, the underlying mechanisms modifying KLF4 activity in mediating vascular function remain poorly understood. Recently, essential roles for S-nitrosation have been implicated in many pathophysiologic processes of cardiovascular disease. Here, we demonstrated that KLF4 could undergo S-nitrosation in response to nitrosative stress in ECs, leading to the decreased nuclear localization with compromised transactivity. Mass-spectrometry and site-directed mutagenesis revealed that S-nitrosation modified KLF4 predominantly at Cys437. Functionally, KLF4 dependent vasodilatory response was impaired after S-nitrosoglutathione (GSNO) treatment. In ECs, endothelin-1 (ET-1) induced KLF4 S-nitrosation, which was inhibited by an endothelin receptor antagonist Bosentan. In hypoxia-induced rat model of pulmonary arterial hypertension (PAH), S-nitrosated KLF4 (SNO-KLF4) was significantly increased in lung tissues, along with decreased nuclear localization of KLF4. In summary, we demonstrated that S-nitrosation is a novel mechanism for the post-translational modification of KLF4 in ECs. Moreover, these findings suggested that KLF4 S-nitrosation may be implicated in the pathogenesis of vascular dysfunction and diseases such as PAH. Elsevier 2019-01-07 /pmc/articles/PMC6348764/ /pubmed/30660098 http://dx.doi.org/10.1016/j.redox.2019.101099 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research Paper Ban, Yiqian Liu, Yahan Li, Yazi Zhang, Yuying Xiao, Lei Gu, Yue Chen, Shaoliang Zhao, Beilei Chen, Chang Wang, Nanping S-nitrosation impairs KLF4 activity and instigates endothelial dysfunction in pulmonary arterial hypertension |
title | S-nitrosation impairs KLF4 activity and instigates endothelial dysfunction in pulmonary arterial hypertension |
title_full | S-nitrosation impairs KLF4 activity and instigates endothelial dysfunction in pulmonary arterial hypertension |
title_fullStr | S-nitrosation impairs KLF4 activity and instigates endothelial dysfunction in pulmonary arterial hypertension |
title_full_unstemmed | S-nitrosation impairs KLF4 activity and instigates endothelial dysfunction in pulmonary arterial hypertension |
title_short | S-nitrosation impairs KLF4 activity and instigates endothelial dysfunction in pulmonary arterial hypertension |
title_sort | s-nitrosation impairs klf4 activity and instigates endothelial dysfunction in pulmonary arterial hypertension |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348764/ https://www.ncbi.nlm.nih.gov/pubmed/30660098 http://dx.doi.org/10.1016/j.redox.2019.101099 |
work_keys_str_mv | AT banyiqian snitrosationimpairsklf4activityandinstigatesendothelialdysfunctioninpulmonaryarterialhypertension AT liuyahan snitrosationimpairsklf4activityandinstigatesendothelialdysfunctioninpulmonaryarterialhypertension AT liyazi snitrosationimpairsklf4activityandinstigatesendothelialdysfunctioninpulmonaryarterialhypertension AT zhangyuying snitrosationimpairsklf4activityandinstigatesendothelialdysfunctioninpulmonaryarterialhypertension AT xiaolei snitrosationimpairsklf4activityandinstigatesendothelialdysfunctioninpulmonaryarterialhypertension AT guyue snitrosationimpairsklf4activityandinstigatesendothelialdysfunctioninpulmonaryarterialhypertension AT chenshaoliang snitrosationimpairsklf4activityandinstigatesendothelialdysfunctioninpulmonaryarterialhypertension AT zhaobeilei snitrosationimpairsklf4activityandinstigatesendothelialdysfunctioninpulmonaryarterialhypertension AT chenchang snitrosationimpairsklf4activityandinstigatesendothelialdysfunctioninpulmonaryarterialhypertension AT wangnanping snitrosationimpairsklf4activityandinstigatesendothelialdysfunctioninpulmonaryarterialhypertension |